Andrew S. Davis, Chief Commercial Officer at Silk Road Medical Inc (SILK), sold 660 shares at $51.16 ($34K) on 2021-04-05, disclosed to the SEC on 2021-04-06.
Scheduled sale ($34k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SILK | SELL | 2023-08-04 | $292K | — | Filing → |
| SILK | SELL | 2023-07-10 | $2K | — | Filing → |
| SILK | SELL | 2023-05-03 | $559K | — | Filing → |